In one aspect, the present invention provides a method of treating breast cancer that is negative for at least one of ER, PR, or HER2, comprising administering to a subject at least one PARP inhibitor. In another aspect, the present invention provides a method of treating breast cancer comprising administering to a subject at least one PARP inhibitor in combination with at least one anti-tumor agent.

 
Web www.patentalert.com

< METHOD FOR PRODUCING MELT-MOLDABLE TETRAFLUOROETHYLENE COPOLYMER

> Process for the preparation of nanoscale particles of elastic material

> DETECTION APPARATUS AND METHOD UTILIZING MEMBRANES AND RATIO OF TRANSMEMBRANE PRESSURES
~ 00519